These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35416193)

  • 21.
    Matsukiyo Y; Yamanaka C; Yamanishi Y
    J Chem Inf Model; 2024 Apr; 64(7):2345-2355. PubMed ID: 37768595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.
    Polykovskiy D; Zhebrak A; Vetrov D; Ivanenkov Y; Aladinskiy V; Mamoshina P; Bozdaganyan M; Aliper A; Zhavoronkov A; Kadurin A
    Mol Pharm; 2018 Oct; 15(10):4398-4405. PubMed ID: 30180591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Navigating the frontier of drug-like chemical space with cutting-edge generative AI models.
    Lavecchia A
    Drug Discov Today; 2024 Sep; 29(9):104133. PubMed ID: 39103144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides.
    Goles M; Daza A; Cabas-Mora G; Sarmiento-Varón L; Sepúlveda-Yañez J; Anvari-Kazemabad H; Davari MD; Uribe-Paredes R; Olivera-Nappa Á; Navarrete MA; Medina-Ortiz D
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38856172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational Approaches for De Novo Drug Design: Past, Present, and Future.
    Liu X; IJzerman AP; van Westen GJP
    Methods Mol Biol; 2021; 2190():139-165. PubMed ID: 32804364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for Design of Molecular Structures with a Desired Pharmacophore Using Deep Reinforcement Learning.
    Yoshimori A; Kawasaki E; Kanai C; Tasaka T
    Chem Pharm Bull (Tokyo); 2020; 68(3):227-233. PubMed ID: 32115529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actively Searching: Inverse Design of Novel Molecules with Simultaneously Optimized Properties.
    Iovanac NC; MacKnight R; Savoie BM
    J Phys Chem A; 2022 Jan; 126(2):333-340. PubMed ID: 34985908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geometric deep learning methods and applications in 3D structure-based drug design.
    Bai Q; Xu T; Huang J; Pérez-Sánchez H
    Drug Discov Today; 2024 Jul; 29(7):104024. PubMed ID: 38759948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretable Machine Learning Models for Molecular Design of Tyrosine Kinase Inhibitors Using Variational Autoencoders and Perturbation-Based Approach of Chemical Space Exploration.
    Krishnan K; Kassab R; Agajanian S; Verkhivker G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MolGPT: Molecular Generation Using a Transformer-Decoder Model.
    Bagal V; Aggarwal R; Vinod PK; Priyakumar UD
    J Chem Inf Model; 2022 May; 62(9):2064-2076. PubMed ID: 34694798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomous Molecular Design: Then and Now.
    Dimitrov T; Kreisbeck C; Becker JS; Aspuru-Guzik A; Saikin SK
    ACS Appl Mater Interfaces; 2019 Jul; 11(28):24825-24836. PubMed ID: 30908004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Generative Models for Molecular Science.
    Jørgensen PB; Schmidt MN; Winther O
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29405647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Silico Target Prediction for Small Molecules.
    Byrne R; Schneider G
    Methods Mol Biol; 2019; 1888():273-309. PubMed ID: 30519953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.
    Wilman W; Wróbel S; Bielska W; Deszynski P; Dudzic P; Jaszczyszyn I; Kaniewski J; Młokosiewicz J; Rouyan A; Satława T; Kumar S; Greiff V; Krawczyk K
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Generative Approach to Materials Discovery, Design, and Optimization.
    Menon D; Ranganathan R
    ACS Omega; 2022 Aug; 7(30):25958-25973. PubMed ID: 35936396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Generative Autoencoder in De Novo Molecular Design.
    Blaschke T; Olivecrona M; Engkvist O; Bajorath J; Chen H
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29235269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.